Tectonic Advisors
JAZZ icon

Tectonic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tectonic Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41M Buy
6,089
+193
+3% +$47.7K 0.07% 152
2026
Q2 		$1.42M Sell
5,896
-56
-0.9% -$12.3K 0.07% 152
2026
Q1 		$1.13M Buy
5,952
+292
+5% +$51K 0.06% 156
2025
Q4 		$962K Buy
5,660
+34
+0.6% +$5.21K 0.05% 173
2025
Q3 		$742K Buy
5,626
+82
+1% +$9.8K 0.04% 196
2025
Q2 		$588K Buy
5,544
+927
+20% +$101K 0.03% 232
2025
Q1 		$573K Buy
4,617
+243
+6% +$31.7K 0.04% 222
2024
Q4 		$539K Buy
4,374
+483
+12% +$56.9K 0.04% 226
2024
Q3 		$433K Buy
3,891
+232
+6% +$25.4K 0.03% 258
2024
Q2 		$391K Buy
3,659
+429
+13% +$47.2K 0.03% 261
2024
Q1 		$389K Buy
3,230
+540
+20% +$66.1K 0.03% 246
2023
Q4 		$331K Buy
2,690
+283
+12% +$35.3K 0.03% 248
2023
Q3 		$312K Buy
+2,407
New +$321K 0.03% 232

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Arbejdsmarkedets Tillaegspension
Arbejdsmarkedets Tillaegspension Hilleroed $3.93B AUM 7.98% 1-Year Est. Return

Tectonic Advisors's JAZZ Position: Q3 2026 in Review

Tectonic Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 3.3% in Q3 2026, buying an estimated $47.7K and bringing the position to 6,089 shares worth $1.41M. The position accounts for 0.07% of the portfolio, ranked #152.

Tectonic Advisors first reported a position in JAZZ in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.42M in Q2 2026. 227 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Tectonic Advisors held 6,089 shares of Jazz Pharmaceuticals worth $1.41M as of Q3 2026.
  • Tectonic Advisors bought 193 Jazz Pharmaceuticals shares in Q3 2026, an estimated $47.7K.
  • Jazz Pharmaceuticals made up 0.07% of Tectonic Advisors's portfolio in Q3 2026, its #152 holding.
  • Tectonic Advisors first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 13 quarters since.
  • Tectonic Advisors's Jazz Pharmaceuticals position peaked at $1.42M in Q2 2026.
  • 227 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Tectonic Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.